Early-Onset Hypothesis of Antipsychotic Drug Action: A Hypothesis Tested, Confirmed and Extended

This publication has 30 references indexed in Scilit:

• Remission in Schizophrenia: Proposed Criteria and Rationale for Consensus
  American Journal of Psychiatry, 2005
• A double-blind, randomized comparative trial of amisulpride versus olanzapine for 6 months in the treatment of schizophrenia
  International Clinical Psychopharmacology, 2004
• Relapse Prevention in Schizophrenia With New-Generation Antipsychotics: A Systematic Review and Exploratory Meta-Analysis of Randomized, Controlled Trials
  American Journal of Psychiatry, 2003
• Atypical and Conventional Antipsychotic Drugs in Treatment-Naive First-Episode Schizophrenia: A 52-Week Randomized Trial of Clozapine Vs Chlorpromazine
  Neuropsychopharmacology, 2003
• Amisulpride vs. Risperidone in Chronic Schizophrenia Results of a 6-month Double-blind Study
  Neuropsychopharmacology, 2002
• Amisulpride has a superior benefit/risk profile to haloperidol in schizophrenia: results of a multicentre, double-blind study (the Amisulpride Study Group^*
  European Psychiatry, 2000
• Long-term safety and efficacy of amisulpride in subchronic or chronic schizophrenia
  International Clinical Psychopharmacology, 2000
• Amisulpride, an atypical antipsychotic, in the treatment of acute episodes of schizophrenia: a dose‐ranging study vs. haloperidol
  Acta Psychiatrica Scandinavica, 1998
• Treatment of Negative Symptoms in Schizophrenia with Amisulpride
  The British Journal of Psychiatry, 1995
• Amisulpride Versus Haloperidol in Treatment of Schizophrenic Patients - Results of a Double-Blind Study
  Pharmacopsychiatry, 1990